Search Results

Evaluación de la eficacia y seguridad de la terapia gravitacional en una cohorte de pacientes con esclerosis sistémica.

• Authors : Servioli, Luisa Fernanda¹ (AUTHOR) ; Isasi, Eugenia^2,3 (AUTHOR); Pérez, Alejandra³ (AUTHOR)

Subjects: *RAYNAUD'S disease; *SYSTEMIC scleroderma; *GRAVITY

• Source: Reumatología Clínica. Nov2024, Vol. 20 Issue 9, p463-469. 7p.

Record details

Development of a core domain set for nailfold capillaroscopy reporting.

• Authors : El Miedany, Yasser¹ (AUTHOR); Ismail, Sherif² (AUTHOR); Wadie, Mary³ (AUTHOR)

Subjects: *CAPILLAROSCOPY; *RAYNAUD'S disease; *EVIDENCE-based medicine

• Source: Reumatología Clínica. Aug2024, Vol. 20 Issue 7, p345-352. 8p.

Record details

Exploring risk factors for Raynaud's phenomenon post COVID-19 vaccination.

• Authors : Ho, Tzu-Chuan¹ (AUTHOR); Chuang, Shih-Chang^2,3 (AUTHOR); Hung, Kuo-Chen^1,2 (AUTHOR)

Subjects: *RAYNAUD'S disease; *COVID-19 vaccines; *AUTOIMMUNE diseases

• Source: Vaccine. Dec2024, Vol. 42 Issue 26, pN.PAG-N.PAG. 1p.

Record details

Association between myeloid disorders and adult onset-inflammatory syndromes, successful treatment with JAK-inhibitors: Case series and literature review.

• Authors : Mishra, Rahul¹ (AUTHOR); Calabrese, Cassandra² (AUTHOR); Jain, Akriti G.³ (AUTHOR)

Subjects: *RAYNAUD'S disease; *BLOOD proteins; *SJOGREN'S syndrome

• Source: Leukemia Research. Nov2024, Vol. 146, pN.PAG-N.PAG. 1p.

Record details

02O Characterization of a mouse model for Jo-1, PL-7 and PL-12 associated anti-synthetase syndrome.

• Authors : Cengiz, D.¹ (AUTHOR); Preusse, C.² (AUTHOR); Lichtenberg, S.¹ (AUTHOR)

Subjects: *RAYNAUD'S disease; *INTERSTITIAL lung diseases; *MUSCLE weakness

• Source: Neuromuscular Disorders. 2024 Supplement 1, Vol. 43, pN.PAG-N.PAG. 1p.

Record details

Tratamiento con oxígeno hiperbárico en el fenómeno de Raynaud y las úlceras digitales asociadas a esclerosis sistémicas.

• Authors : Ahijón-Lana, María¹ (AUTHOR) ; Baragaño-Ordóñez, Elia² (AUTHOR); Veiga-Cabello, Raúl¹ (AUTHOR)

Subjects: *RAYNAUD'S disease; *SYSTEMIC scleroderma; *CHRONIC wounds & injuries

• Source: Reumatología Clínica. Apr2022, Vol. 18 Issue 4, p246-248. 3p.

Record details

Primary Raynaud's phenomenon, very early and early scleroderma tips for a timely diagnosis.

• Authors : Sirufo, Maria Maddalena^1,2 (AUTHOR); Magnanimi, Lina Maria¹ (AUTHOR); Ginaldi, Lia^1,2 (AUTHOR)

Subjects: *RAYNAUD'S disease; *CONNECTIVE tissue diseases; *DIAGNOSIS

• Source: European Journal of Internal Medicine. Apr2022, Vol. 98, p111-112. 2p.

Record details

Association of neutrophil extracellular trap levels with Raynaud's phenomenon, glomerulonephritis and disease index score in SLE patients from Brazil.

• Authors : Delabio Auer, Eduardo¹ (AUTHOR); Bumiller-Bini Hoch, Valéria¹ (AUTHOR); Borges da Silva, Emiliano² (AUTHOR)

Subjects: *RAYNAUD'S disease; *GLOMERULONEPHRITIS; *SYSTEMIC lupus erythematosusBRAZIL

• Source: Immunobiology. May2024, Vol. 229 Issue 3, pN.PAG-N.PAG. 1p.

Record details

Raynaud's disease. (Eponym).

• Authors : Bowling, JCR; Dowd, PM

• Source: The Lancet. 2003, Vol. 361, Issue 9374, pages. 2078

Record details

Dynamic CTA and MRA in a case of severe Raynaud's phenomenon.

• Authors : Hislop-Jambrich, Jacqueline L.¹ (AUTHOR) ; Troupis, John M.² (AUTHOR); Littlejohn, Geoffrey³ (AUTHOR)

Subjects: *RAYNAUD'S disease; *BLOOD flow; *SYMPTOMS

• Source: Clinical Imaging. Oct2020, Vol. 66, p133-136. 4p.

Record details